Common use of Validation Review Clause in Contracts

Validation Review. In the event OIG has reason to believe that: (a) any of BIPI’s IRO Reviews fails to conform to the requirements of this CIA; or (b) the IRO’s findings or Review results are inaccurate, OIG may, at its sole discretion, conduct its own review to determine whether the applicable IRO Review complied with the requirements of the CIA and/or the findings or Review results are inaccurate (Validation Review). BIPI shall pay for the reasonable cost of any such review performed by OIG or any of its designated agents. Any Validation Review of Reports submitted as part of BIPI’s final Annual Report shall be initiated no later than one year after ▇▇▇▇’s final submission (as described in Section II) is received by OIG. Prior to initiating a Validation Review, OIG shall notify BIPI of its intent to do so and provide a written explanation of why OIG believes such a review is necessary. To resolve any concerns raised by OIG, ▇▇▇▇ may request a meeting with OIG to: (a) discuss the results of any IRO Review submissions or findings; (b) present any additional information to clarify the results of the IRO Review or to correct the inaccuracy of the IRO Review; and/or (c) propose alternatives to the proposed Validation Review. ▇▇▇▇ agrees to provide any additional information as may be requested by OIG under this Section III.D.3 in an expedited manner. OIG will attempt in good faith to resolve any IRO Review issues with BIPI prior to conducting a Validation Review. However, the final determination as to whether or not to proceed with a Validation Review shall be made at the sole discretion of OIG.

Appears in 1 contract

Sources: Corporate Integrity Agreement

Validation Review. In the event OIG has reason to believe that: (a) any of BIPI’s the IRO Reviews fails to conform to the requirements of this CIA; or (b) the IRO’s findings or Review results are inaccurate, OIG may, at its sole discretion, conduct its own review to determine whether the applicable IRO Review in question complied with the requirements of the CIA and/or the findings or Review results are inaccurate (Validation Review). BIPI Jazz shall pay for the reasonable cost of any such review performed by OIG or any of its designated agents. Any Validation Review of Reports submitted as part of BIPIJazz’s final Annual Report shall be initiated no later than one year after ▇▇▇▇Jazz’s final submission (as described in Section II) is received by OIG. Prior to initiating a Validation Review, OIG shall notify BIPI Jazz of its intent to do so and provide a written explanation of why OIG believes such a review is necessary. To resolve any concerns raised by OIG, ▇▇▇▇ Jazz may request a meeting with OIG to: (a) discuss the results of any IRO Review submissions or findings; (b) present any additional information to clarify the results of the IRO Review in question or to correct the inaccuracy of the IRO Review; and/or (c) propose alternatives to the proposed Validation Review. ▇▇▇▇ Jazz agrees to provide any additional information as may be requested by OIG under this Section III.D.3 in an expedited manner. OIG will attempt in good faith to resolve any IRO Review issues with BIPI Jazz prior to conducting a Validation Review. However, the final determination as to whether or not to proceed with a Validation Review shall be made at the sole discretion of OIG.

Appears in 1 contract

Sources: Corporate Integrity Agreement (Jazz Pharmaceuticals Inc)

Validation Review. In the event OIG has reason to believe that: (a) any of BIPI’s IRO Reviews Review fails to conform to the requirements of this CIA; or (b) the IRO’s findings or Review results are inaccurate, OIG may, at its sole discretion, conduct its own review to determine whether the applicable IRO Review complied with the requirements of the CIA and/or the findings or Review results are inaccurate (Validation Review). BIPI Elan shall pay for the reasonable cost of any such review performed by OIG or any of its designated agents. Any Validation Review of Reports submitted as part of BIPIElan’s final Annual Report shall be initiated no later than one year after ▇▇▇▇Elan’s final submission (as described in Section II) is received by OIG. Prior to initiating a Validation Review, OIG shall notify BIPI Elan of its intent to do so and provide a written explanation of why OIG believes such a review is necessary. To resolve any concerns raised by OIG, ▇▇▇▇ Elan may request a meeting with OIG to: (a) discuss the results of any IRO Review submissions or findings; (b) present any additional information to clarify the results of the IRO applicable Review or to correct the inaccuracy of the IRO Review; and/or (c) propose alternatives to the proposed Validation Review. ▇▇▇▇ Elan agrees to provide any additional information as may be requested by OIG under this Section III.D.3 in an expedited manner. OIG will attempt in good faith to resolve any IRO Review issues with BIPI Elan prior to conducting a Validation Review. However, the final determination as to whether or not to proceed with a Validation Review shall be made at the sole discretion of OIG.

Appears in 1 contract

Sources: Corporate Integrity Agreement (Elan Corp PLC)

Validation Review. In the event OIG has reason to believe that: (a) that any of BIPI’s the IRO Reviews fails to conform to the requirements of this CIAAgreement; or (b) the IRO’s findings or Review results are inaccurate, OIG may, at its sole discretion, conduct its own review to determine whether the applicable IRO Review Reviews complied with the requirements of the CIA Agreement and/or the findings or Review results are inaccurate (Validation Review). BIPI T▇▇▇▇ shall pay for the reasonable cost of any such review performed by OIG or any of its designated agents. Any Validation Review of Reports submitted as part of BIPI’s T▇▇▇▇’▇ final Annual Report shall must be initiated no later than one year after T▇▇▇▇’s ’▇ final submission (as described in Section IIII of the CIA) is received by OIG. Prior to initiating a Validation Review, OIG shall notify BIPI T▇▇▇▇ of its intent to do so and provide a written explanation of why OIG believes such a review is necessary. To resolve any concerns raised by OIG, T▇▇▇▇ may request a meeting with OIG to: (a) discuss the results of any IRO Review submissions or findings; (b) present any additional information to clarify the results of the IRO Review Reviews or to correct the inaccuracy of the IRO ReviewReviews; and/or (c) propose alternatives to the proposed Validation Review. T▇▇▇▇ agrees to provide any additional information as may be requested by OIG under this Section III.D.3 in an expedited manner. OIG will attempt in good faith to resolve any IRO Review issues with BIPI T▇▇▇▇ prior to conducting a Validation Review. However, the final determination as to whether or not to proceed with a Validation Review shall be made at the sole discretion of OIG.

Appears in 1 contract

Sources: Corporate Integrity Agreement (Tenet Healthcare Corp)

Validation Review. In the event OIG has reason to believe that: (a) any of BIPIBaptist’s IRO Reviews Claims Review fails to conform to the requirements of this CIA; or or, (b) the IRO’s findings or Claims Review results are inaccurate, OIG may, at its sole discretion, conduct its own review to determine whether the applicable IRO Claims Review complied with the requirements of the CIA and/or the findings or Claims Review results are inaccurate (Validation Review). BIPI Baptist shall pay for the reasonable cost of any such review performed by OIG or any of its designated agents. Any Validation Review of Reports submitted as part of BIPIBaptist’s final Annual Report shall be initiated no later than one year after ▇▇▇▇Baptist’s final submission (as described in Section II) is received by OIG. Prior to initiating a Validation Review, OIG shall notify BIPI Baptist of its intent to do so and provide a written explanation of why OIG believes such a review is necessary. To resolve any concerns raised by OIG, ▇▇▇▇ Baptist may request a meeting with OIG to: (a) discuss the results of any IRO Claims Review submissions or findings; (b) present any additional information to clarify the results of the IRO Claims Review or to correct the inaccuracy of the IRO Claims Review; and/or and/or, (c) propose alternatives to the proposed Validation Review. ▇▇▇▇▇▇▇ agrees to provide any additional information as may be requested by OIG under this Section III.D.3 III.D.5 in an expedited manner. OIG will attempt in good faith to resolve any IRO Claims Review issues with BIPI Baptist prior to conducting a Validation Review. However, the final determination as to whether or not to proceed with a Validation Review shall be made at the sole discretion of OIG.

Appears in 1 contract

Sources: Corporate Integrity Agreement

Validation Review. In the event OIG has reason to believe that: (a) any of BIPIPar’s IRO Reviews fails to conform to the requirements of this CIA; or (b) the IRO’s findings or Review results are inaccurate, OIG may, at its sole discretion, conduct its own review to determine whether the applicable IRO Review complied with the requirements of the CIA and/or the findings or Review results are inaccurate (Validation Review). BIPI Par shall pay for the reasonable cost of any such review performed by OIG or any of its designated agents. Any Validation Review of Reports submitted as part of BIPIPar’s final Annual Report shall be initiated no later than one year after ▇▇▇▇Par’s final submission (as described in Section II) is received by OIG. Prior to initiating a Validation Review, OIG shall notify BIPI Par of its intent to do so and provide a written explanation of why OIG believes such a review is necessary. To resolve any concerns raised by OIG, ▇▇▇ may request a meeting with OIG to: (a) discuss the results of any IRO Review submissions or findings; (b) present any additional information to clarify the results of the IRO Review or to correct the inaccuracy of the IRO Review; and/or (c) propose alternatives to the proposed Validation Review. ▇▇▇▇ Par agrees to provide any additional information as may be requested by OIG under this Section III.D.3 III.E.3 in an expedited manner. OIG will attempt in good faith to resolve any IRO Review issues with BIPI Par prior to conducting a Validation Review. However, the final determination as to whether or not to proceed with a Validation Review shall be made at the sole discretion of OIG.

Appears in 1 contract

Sources: Corporate Integrity Agreement

Validation Review. In the event OIG has reason to believe that: (a) any of BIPI’s IRO Reviews Review fails to conform to the requirements of this CIA; or (b) the IRO’s findings or Review results are inaccurate, OIG may, at its sole discretion, conduct its own review to determine whether the applicable IRO Review complied with the requirements of the CIA and/or the findings or Review results are inaccurate (Validation Review). BIPI Cephalon shall pay for the reasonable cost of any such review performed by OIG or any of its designated agents. Any Validation Review of Reports submitted as part of BIPICephalon’s final Annual Report shall be initiated no later than one year after ▇▇▇▇Cephalon’s final submission (as described in Section II) is received by OIG. Prior to initiating a Validation Review, OIG shall notify BIPI Cephalon of its intent to do so and provide a written explanation of why OIG believes such a review is necessary. To resolve any concerns raised by OIG, ▇▇▇▇ Cephalon may request a meeting with OIG to: (a) discuss the results of any IRO Review submissions or findings; (b) present any additional information to clarify the results of the IRO applicable Review or to correct the inaccuracy of the IRO Review; and/or (c) propose alternatives to the proposed Validation Review. ▇▇▇▇ Cephalon agrees to provide any additional information as may be requested by OIG under this Section III.D.3 in an expedited manner. OIG will attempt in good faith to resolve any IRO Review issues with BIPI Cephalon prior to conducting a Validation Review. However, the final determination as to whether or not to proceed with a Validation Review shall be made at the sole discretion of OIG.

Appears in 1 contract

Sources: Corporate Integrity Agreement (Cephalon Inc)